InvestorsHub Logo
Followers 14
Posts 817
Boards Moderated 0
Alias Born 02/24/2010

Re: govorchin post# 71235

Sunday, 09/28/2014 3:39:39 PM

Sunday, September 28, 2014 3:39:39 PM

Post# of 403754
Gov. good point, these pharma that have 1 or 2 drugs phase 1 with 1-5 billion market caps may have given away too many rights to big pharma too early for short term gain. Leo's strategy of developing them first in the long-run should be best for shareholder equity. Powder-keg situation!

Still frustrating though. Clovis etc often have drugs for rare cancers no big revenue projections but a faster path to approval but Cellceutix have this as well with there big 3 and it takes a massive tornado of data releases and news catalysts to get us to a 300m market cap.

Hopefully a reckoning is at hand here now!